Effect of febuxostat in patients with chronic kidney disease
Not Applicable
- Conditions
- chronic kidney disease, hyperuricemia
- Registration Number
- JPRN-UMIN000007481
- Lead Sponsor
- Fukushima Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with acute/chronic inflammatory disease and/or malignancy. 2. Patients with severe cardiovascular/respiratory/digestive disease within past 6 months. 3. Woman who is pregnant. 4. Patients who medicated with febuxostat and/or benzbromarone within past 3 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Urinary tubular markers 2. Urinary albumin excretion 3. Serum systatin C, eGFR
- Secondary Outcome Measures
Name Time Method